Live from the NIH registry
Studies recruiting near Colorado Springs right now
Top 25 of 205 recruiting studies, sorted by proximity — each links to its official registry page
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2, Phase 3
Interventional 786 participants sought
Alkermes Investigational Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Alkermes, Inc.
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Eli Lilly and Company
A Study of Depemokimab in Participants of 6 to 11 Years of Age
Asthma
Phase 3
Interventional 34 participants sought
GSK Investigational Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: GlaxoSmithKline
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Schizophrenia, Bipolar I Disorder
Phase 3
Interventional 220 participants sought
Alkermes Investigator Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Alkermes, Inc.
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
Phase 2
Interventional 54 participants sought
Children's Hospital of Colorado — Colorado Springs, Colorado (4.0 mi)
· Sponsor: St. Jude Children's Research Hospital
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: NRG Oncology
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Narcolepsy Type 1
Phase 2, Phase 3
Interventional 500 participants sought
Delta Waves LLC - Hunt - PPDS — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Takeda
Effects of Physical and Psychosocial Stress on Functional Hypothalamic Amenorrhea in Exercising Women
Amenorrhea Secondary
N/A
Interventional 54 participants sought
University of Colorado Colorado Springs — Colorado Springs, Colorado (4.0 mi)
· Sponsor: University of Colorado, Colorado Springs
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: TG Therapeutics, Inc.
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
Local Institution - 0203 — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Bristol-Myers Squibb
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
N/A
Interventional 300 participants sought
Colorado ENT & Allergy — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Airiver Medical, Inc.
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Akero Therapeutics, Inc
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
UCHealth Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
Chronic Rhinosinusitis Without Nasal Polyps
Phase 3
Interventional 84 participants sought
Colorado ENT & Allergy — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Optinose US Inc.
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
UCHealth Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: National Cancer Institute (NCI)
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Non-Small Cell Lung Cancer
Phase 3
Interventional 272 participants sought
Penrose Cancer Center — Colorado Springs, Colorado (4.0 mi)
· Sponsor: University of Texas Southwestern Medical Center
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 3
Interventional 530 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Neovascular Age-related Macular Degeneration, nAMD
Phase 3
Interventional 304 participants sought
Retina Consultants of Southern Colorado (Colorado Springs)- RCA — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Amgen
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Asthma
Phase 2
Interventional 531 participants sought
Asthma & Allergy Associates - Colorado Springs — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Eli Lilly and Company
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Idiopathic Hypersomnia
Phase 3
Interventional 248 participants sought
Delta Waves LLC — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Harmony Biosciences Management, Inc.
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: National Cancer Institute (NCI)
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: NRG Oncology
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
UCHealth Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Rocky Mountain Cancer Centers, LLP — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Pfizer